Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


18.12.2017

5 Am J Respir Crit Care Med
1 Antimicrob Agents Chemother
2 Chest
1 J Antimicrob Chemother
1 J Infect Dis
2 Lancet Infect Dis
1 Lancet Respir Med
2 N Engl J Med
1 PLoS Med
1 PLoS One
1 Respir Med
1 Trop Med Int Health


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Respir Crit Care Med

  1. BARRY PM, Lowenthal P, True L, Henry L, et al
    Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.
    Am J Respir Crit Care Med. 2017;196:1488-1489.
    PubMed     Text format    

  2. DHEDA K
    The Multistep Tuberculosis Diagnostic Cascade. More Than Meets the Eye.
    Am J Respir Crit Care Med. 2017;196:809-811.
    PubMed     Text format    

  3. VARAINE F, Guglielmetti L, Mitnick CD
    Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.
    Am J Respir Crit Care Med. 2017;196:1490-1491.
    PubMed     Text format    

  4. VAN LETH F, Gunther G, Hoffmann H, Lange C, et al
    Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.
    Am J Respir Crit Care Med. 2017;196:1489-1490.
    PubMed     Text format    

  5. STOUT JE, Dicks KV
    A Breath of Fresh Air for Patients with Pulmonary Nontuberculous Mycobacterial Infection.
    Am J Respir Crit Care Med. 2017;195:716-717.
    PubMed     Text format    


    Antimicrob Agents Chemother

  6. ROBERTS O, Khoo S, Owen A, Siccardi M, et al
    Interaction of Rifampicin and Darunavir/Ritonavir or Darunavir/Cobicistat In Vitro.
    Antimicrob Agents Chemother. 2017 Feb 13. pii: AAC.01776.
    PubMed     Text format     Abstract available


    Chest

  7. CORREA V, Vintch J, Lanks C
    A 26-Year-Old Man From Mexico With Headaches, Dysuria, and a Right Scrotal Mass.
    Chest. 2017;152:e147-e150.
    PubMed     Text format     Abstract available

  8. DONG Z, Shi J, Dorhoi A, Zhang J, et al
    Hemostasis and lipoprotein indices signify exacerbated lung injury in tuberculosis with diabetes comorbidity.
    Chest. 2017 Dec 7. pii: S0012-3692(17)33208-7. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


    J Antimicrob Chemother

  9. LIU Y, Pertinez H, Ortega-Muro F, Alameda-Martin L, et al
    Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria.
    J Antimicrob Chemother. 2017 Dec 12. pii: 4735127. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Infect Dis

  10. ZHENG R, Liu H, Zhou Y, Yan D, et al
    Notch4 Negatively Regulates the Inflammatory Response to Mycobacterium tuberculosis Infection by Inhibiting TAK1 Activation.
    J Infect Dis. 2017 Dec 8. pii: 4712145. doi: 10.1093.
    PubMed     Text format     Abstract available


    Lancet Infect Dis


  11. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015.
    Lancet Infect Dis. 2017 Dec 6. pii: S1473-3099(17)30703.
    PubMed     Text format     Abstract available

  12. COX H, Nicol MP
    Tuberculosis eradication: renewed commitment and global investment required.
    Lancet Infect Dis. 2017 Dec 6. pii: S1473-3099(17)30692.
    PubMed     Text format    


    Lancet Respir Med

  13. BURKI TK
    The global cost of tuberculosis.
    Lancet Respir Med. 2017 Nov 24. pii: S2213-2600(17)30468.
    PubMed     Text format    


    N Engl J Med

  14. MAITRE T, Aubry A, Veziris N
    Molecular Drug-Susceptibility Test for Tuberculosis.
    N Engl J Med. 2017;377:2403-4.
    PubMed     Text format    


  15. Molecular Drug-Susceptibility Test for Tuberculosis.
    N Engl J Med. 2017;377:2403-2404.
    PubMed     Text format    


    PLoS Med

  16. KENDALL EA, Schumacher SG, Denkinger CM, Dowdy DW, et al
    Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.
    PLoS Med. 2017;14:e1002472.
    PubMed     Text format     Abstract available


    PLoS One

  17. SINGH B, Saqib M, Gupta A, Kumar P, et al
    Autophagy induction by Mycobacterium indicus pranii promotes Mycobacterium tuberculosis clearance from RAW 264.7 macrophages.
    PLoS One. 2017;12:e0189606.
    PubMed     Text format     Abstract available


    Respir Med

  18. BOTHAMLEY GH, Lange C
    Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study.
    Respir Med. 2017;132:68-75.
    PubMed     Text format     Abstract available


    Trop Med Int Health

  19. BEDELL RA, van Lettow M, Meaney C, Corbett EL, et al
    Predictive value of C-reactive protein for tuberculosis, bloodstream infection or death among HIV-infected individuals with chronic, non-specific symptoms and negative sputum smear microscopy.
    Trop Med Int Health. 2017 Dec 15. doi: 10.1111/tmi.13025.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: